ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Endocrine-Related Cancer 14 (4) 907-933    DOI: 10.1677/ERC-07-0137
Copyright © 2007 by the Society for Endocrinology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Britt, K.
Right arrow Articles by Smalley, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Britt, K.
Right arrow Articles by Smalley, M.

Pregnancy and the risk of breast cancer

 Kara Britt1,2, Alan Ashworth1 and Matthew Smalley1

1 Institute of Cancer Research,, The Breakthrough Breast Cancer Research Centre, 237 Fulham Road, London SW3 6JB, UK 2 The Garvan Institute of Medical Research,, Darlinghurst, Sydney 2010, Australia

(Correspondence should be addressed to K Britt; Email: kara.britt{at}icr.ac.uk)

It is well established that childless women and women having children later in life are at an increased risk of developing breast cancer. In particular, women having a first child before 20 years of age have a 50% reduction in lifetime breast cancer risk when compared with women who do not have children. This protective effect is specific for estrogen receptor positive breast cancer. Nevertheless, it remains unclear how parity decreases breast cancer risk. Possible mechanisms of action include changes to the hormonal profile of parous women, a more differentiated and so less susceptible mammary gland or changes within specific epithelial cell subpopulations. In this review, we discuss the epidemiological evidence for the protective effects of parity on breast cancer. We also explore the mechanisms by which parity protects, with a particular emphasis on the role of stem cells and the interactions between stem cells and estrogen.




This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
C. Chargari, L. Vedrine, O. Bauduceau, S. Le Moulec, B. Ceccaldi, and N. Magne
Reapprasial of the role of endocrine therapy in meningioma management
Endocr. Relat. Cancer, December 1, 2008; 15(4): 931 - 941.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S. K. Siwko, J. Dong, M. T. Lewis, H. Liu, S. G. Hilsenbeck, and Y. Li
Evidence That an Early Pregnancy Causes a Persistent Decrease in the Number of Functional Mammary Epithelial Stem Cells--Implications for Pregnancy-Induced Protection Against Breast Cancer
Stem Cells, December 1, 2008; 26(12): 3205 - 3209.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
M.-L. Asselin-Labat, F. Vaillant, M. Shackleton, T. Bouras, G.J. Lindeman, and J.E. Visvader
Delineating the Epithelial Hierarchy in the Mouse Mammary Gland
Cold Spring Harb Symp Quant Biol, November 19, 2008; (2008) sqb.2008.73.020v2.
[Abstract] [PDF]

Home page
 JCOHome page
M. Kakarala and M. S. Wicha
Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
J. Clin. Oncol., June 10, 2008; 26(17): 2813 - 2820.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Endocrinology.